Phenominer

Phenominer Database Results (125 results)

Colored By:

DL-α-aminoadipate (70 ug/ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-0.5 log(cd x m/s2))
DL-α-aminoadipate (70 ug/ul) and 2-methyl-6-(phenylethynyl)pyridine (200 umol) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-4.5 log(cd x m/s2))
phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-0.5 log(cd x m/s2))
DL-α-aminoadipate (70 ug/ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-0.02 log(cd x m/s2))
gene transfer using empty plasmid vector pVAX2 (30 ug) and gene transfer using empty plasmid vector pVAX2 (30 ug) then controlled exposure to darkness (for 1 days) then visible light stimulus (3 cd x s/m2)
DL-α-aminoadipate (70 ug/ul) and phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (1 log(cd x m/s2))
2-methyl-6-(phenylethynyl)pyridine (200 umol) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-0.5 log(cd x m/s2))
DL-α-aminoadipate (70 ug/ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (1 log(cd x m/s2))
2-Chloro-5-hydroxyphenylglycine (200 umol) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-0.02 log(cd x m/s2))
DL-α-aminoadipate (70 ug/ul) and 2-methyl-6-(phenylethynyl)pyridine (200 umol) then controlled exposure to darkness (for 12 hours) then visible light stimulus (0.5 log(cd x m/s2))
2-Chloro-5-hydroxyphenylglycine (200 umol) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-0.5 log(cd x m/s2))
gene transfer of the rat GDNF gene using the plasmid vector pVAX2 (30 ug) then controlled exposure to darkness (for 1 days) then visible light stimulus (3 cd x s/m2)
2-methyl-6-(phenylethynyl)pyridine (200 umol) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-0.02 log(cd x m/s2))
2-Chloro-5-hydroxyphenylglycine (200 umol) then controlled exposure to darkness (for 12 hours) then visible light stimulus (0.5 log(cd x m/s2))
DL-α-aminoadipate (70 ug/ul) and phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (0.5 log(cd x m/s2))
phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (0.5 log(cd x m/s2))
DL-α-aminoadipate (70 ug/ul) and 2-methyl-6-(phenylethynyl)pyridine (200 umol) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-0.5 log(cd x m/s2))
phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (1 log(cd x m/s2))
2-methyl-6-(phenylethynyl)pyridine (200 umol) then controlled exposure to darkness (for 12 hours) then visible light stimulus (1 log(cd x m/s2))
phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-0.02 log(cd x m/s2))
2-Chloro-5-hydroxyphenylglycine (200 umol) then controlled exposure to darkness (for 12 hours) then visible light stimulus (1 log(cd x m/s2))
DL-α-aminoadipate (70 ug/ul) and 2-methyl-6-(phenylethynyl)pyridine (200 umol) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-2.5 log(cd x m/s2))
gene transfer of the rat MER proto-oncogene, tyrosine kinase gene using an adenovirus vector (4 x 10E8 vg) then controlled exposure to darkness (for 12 hours) then visible light stimulus (5 cd/m2)
phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-4.5 log(cd x m/s2))
DL-α-aminoadipate (70 ug/ul) and phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-0.5 log(cd x m/s2))
gene transfer of the rat MER proto-oncogene, tyrosine kinase gene using an adenovirus vector (40 x 10E8 vg) then controlled exposure to darkness (for 12 hours) then visible light stimulus (5 cd/m2)
control condition then controlled exposure to darkness (for 1 days) then visible light stimulus (3 cd x s/m2)
vehicle control condition (2 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (5 cd/m2)
2-Chloro-5-hydroxyphenylglycine (200 umol) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-2.5 log(cd x m/s2))
2-methyl-6-(phenylethynyl)pyridine (200 umol) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-2.5 log(cd x m/s2))
DL-α-aminoadipate (70 ug/ul) and phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-4.5 log(cd x m/s2))
controlled exposure to darkness (for 12 hours) then visible light stimulus
DL-α-aminoadipate (70 ug/ul) and 2-methyl-6-(phenylethynyl)pyridine (200 umol) then controlled exposure to darkness (for 12 hours) then visible light stimulus (1 log(cd x m/s2))
gene transfer using empty plasmid vector pVAX2 (30 ug) then controlled exposure to darkness (for 1 days) then visible light stimulus (3 cd x s/m2)
gene transfer of the rat MER proto-oncogene, tyrosine kinase gene using an adenovirus vector (21.6 x 10E8 vg) then controlled exposure to darkness (for 12 hours) then visible light stimulus (0.01 cd x s/m2)
gene transfer of the rat GDNF gene using the plasmid vector pVAX2 (15 ug) and gene transfer of the rat GDNF gene using the plasmid vector pVAX2 (15 ug) then controlled exposure to darkness (for 1 days) then visible light stimulus (3 cd x s/m2)
2-methyl-6-(phenylethynyl)pyridine (200 umol) then controlled exposure to darkness (for 12 hours) then visible light stimulus (0.5 log(cd x m/s2))
control condition then controlled exposure to darkness (for 12 hours) then visible light stimulus (2.5 cd x s/m2)
phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-2.5 log(cd x m/s2))
gene transfer of the lin-28 homolog B gene using an adenovirus vector (5250000 PFU) then controlled exposure to darkness (for 12 hours)
human periodontal ligament-derived stem cells (0.2 x 10E6 cells) then controlled exposure to darkness (for 12 hours) then visible light stimulus
2-Chloro-5-hydroxyphenylglycine (200 umol) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-4.5 log(cd x m/s2))
lensotomy then controlled exposure to darkness (for 1 days) then visible light stimulus (100 cd x s/m2)
gene transfer of the rat GDNF gene using the plasmid vector pVAX2 (30 ug) and gene transfer of the rat GDNF gene using the plasmid vector pVAX2 (30 ug) then controlled exposure to darkness (for 1 days) then visible light stimulus (3 cd x s/m2)
DL-α-aminoadipate (70 ug/ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-4.5 log(cd x m/s2))
DL-α-aminoadipate (70 ug/ul) and 2-methyl-6-(phenylethynyl)pyridine (200 umol) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-0.02 log(cd x m/s2))
DL-α-aminoadipate (70 ug/ul) and phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-2.5 log(cd x m/s2))
DL-α-aminoadipate (70 ug/ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-2.5 log(cd x m/s2))
DL-α-aminoadipate (70 ug/ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (0.5 log(cd x m/s2))
DL-α-aminoadipate (70 ug/ul) and phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-0.02 log(cd x m/s2))
vehicle control condition (2 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus
controlled exposure to darkness (for 12 hours) then visible light stimulus (5 cd/m2)
2-methyl-6-(phenylethynyl)pyridine (200 umol) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-4.5 log(cd x m/s2))
control condition then controlled exposure to darkness (for 12 hours)
gene transfer of the enhanced green fluorescent protein gene using an adenovirus vector (5250000 PFU) then controlled exposure to darkness (for 12 hours)
gene transfer of the rat MER proto-oncogene, tyrosine kinase gene using an adenovirus vector (21.6 x 10E8 vg) then controlled exposure to darkness (for 12 hours) then visible light stimulus (2.5 cd x s/m2)

Table "column sort" updates the order of the bars in the chart.

Strain	Phenotype	Conditions	Study	Experiment Name	Sex	Age	# of Animals	Value	Units	SEM	SD	Method	Method Site	Post Insult Type	Post Insult Time Value	Post Insult Time Unit	Method Notes	Clinical Measurement Notes	Record ID	Study ID
Hsd:SD	scotopic B wave amplitude of ERG waveform	controlled exposure to darkness (for 12 hours) then visible light stimulus (5 cd/m2)	Conlon TJ, et al., Hum Gene Ther Clin Dev. 2013 Mar;24(1):23-8. doi: 10.1089/humc.2013.037. Epub 2013 Apr 3.	rod electrophysiology trait	both	0 days	4	456.0	uV			electroretinography	cornea		0			scotopic b-wave ERG	108641	3128
Hsd:SD	scotopic B wave amplitude of ERG waveform	vehicle control condition (2 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (5 cd/m2)	Conlon TJ, et al., Hum Gene Ther Clin Dev. 2013 Mar;24(1):23-8. doi: 10.1089/humc.2013.037. Epub 2013 Apr 3.	rod electrophysiology trait	both	0 days	4	338.0	uV			electroretinography	cornea	subretinal injection	30	days		scotopic b-wave ERG	108640	3128
RCS-p+/LavRrrc	scotopic B wave amplitude of ERG waveform	gene transfer using empty plasmid vector pVAX2 (30 ug) then controlled exposure to darkness (for 1 days) then visible light stimulus (3 cd x s/m2)	Touchard E, et al., Gene Ther. 2012 Sep;19(9):886-98. doi: 10.1038/gt.2011.154. Epub 2011 Oct 13.	rod electrophysiology trait	both	75 days	5	114.0	uV	16.1	36.0	electroretinography	cornea	plasmid delivery	59	days		scotopic b-wave ERG	108703	3131
RCS-rdy+ p+/LavRrrc	scotopic B wave amplitude of ERG waveform	DL-α-aminoadipate (70 ug/ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (0.5 log(cd x m/s2))	Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z.	rod electrophysiology trait	both	0 days	6	411.83	uV	43.52	106.6	electroretinography	cornea	subretinal injection	7	days	dl-aaa	b-wave amplitude ERG	108408	3123
RCS-rdy+ p+/LavRrrc	scotopic B wave amplitude of ERG waveform	phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-4.5 log(cd x m/s2))	Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z.	rod electrophysiology trait	both	0 days	6	62.22	uV	18.42	45.12	electroretinography	cornea	subretinal injection	7	days	dl-aaa	b-wave amplitude ERG	108410	3123
RCS-rdy+ p+/LavRrrc	scotopic B wave amplitude of ERG waveform	phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (1 log(cd x m/s2))	Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z.	rod electrophysiology trait	both	0 days	6	652.5	uV	65.65	160.81	electroretinography	cornea	subretinal injection	7	days	dl-aaa	b-wave amplitude ERG	108415	3123
RCS-rdy+ p+/LavRrrc	scotopic B wave amplitude of ERG waveform	DL-α-aminoadipate (70 ug/ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-2.5 log(cd x m/s2))	Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z.	rod electrophysiology trait	both	0 days	6	373.83	uV	17.47	42.79	electroretinography	cornea	subretinal injection	10	days	dl-aaa	b-wave amplitude ERG	108429	3123
RCS-rdy+ p+/LavRrrc	scotopic B wave amplitude of ERG waveform	DL-α-aminoadipate (70 ug/ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-0.02 log(cd x m/s2))	Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z.	rod electrophysiology trait	both	0 days	6	437.0	uV	33.32	81.62	electroretinography	cornea	subretinal injection	10	days	dl-aaa	b-wave amplitude ERG	108431	3123
RCS-rdy+ p+/LavRrrc	scotopic B wave amplitude of ERG waveform	DL-α-aminoadipate (70 ug/ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (1 log(cd x m/s2))	Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z.	rod electrophysiology trait	both	0 days	6	594.5	uV	24.04	58.89	electroretinography	cornea	subretinal injection	10	days	dl-aaa	b-wave amplitude ERG	108433	3123
RCS-rdy+ p+/LavRrrc	scotopic B wave amplitude of ERG waveform	phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (1 log(cd x m/s2))	Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z.	rod electrophysiology trait	both	0 days	6	598.67	uV	39.64	97.1	electroretinography	cornea	subretinal injection	30	min	pbs	b-wave amplitude ERG	108463	3123
RCS-rdy+ p+/LavRrrc	scotopic B wave amplitude of ERG waveform	2-Chloro-5-hydroxyphenylglycine (200 umol) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-2.5 log(cd x m/s2))	Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z.	rod electrophysiology trait	both	0 days	11	270.09	uV	34.35	113.93	electroretinography	cornea	subretinal injection	2	days	CHPG	b-wave amplitude ERG	108477	3123
RCS-rdy+ p+/LavRrrc	scotopic B wave amplitude of ERG waveform	phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-0.5 log(cd x m/s2))	Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z.	rod electrophysiology trait	both	0 days	11	466.45	uV	51.69	171.44	electroretinography	cornea	subretinal injection	2	days	pbs	b wave amplitude ERG	108484	3123
RCS-rdy+ p+/LavRrrc	scotopic B wave amplitude of ERG waveform	phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-0.02 log(cd x m/s2))	Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z.	rod electrophysiology trait	both	0 days	11	518.55	uV	54.69	181.39	electroretinography	cornea	subretinal injection	2	days	pbs	b wave amplitude ERG	108485	3123
RCS-rdy+ p+/LavRrrc	scotopic B wave amplitude of ERG waveform	2-Chloro-5-hydroxyphenylglycine (200 umol) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-2.5 log(cd x m/s2))	Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z.	rod electrophysiology trait	both	0 days	6	385.17	uV	61.99	151.84	electroretinography	cornea	subretinal injection	10	days	CHPG	b-wave amplitude ERG	108501	3123
RCS-rdy+ p+/LavRrrc	scotopic B wave amplitude of ERG waveform	2-Chloro-5-hydroxyphenylglycine (200 umol) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-0.5 log(cd x m/s2))	Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z.	rod electrophysiology trait	both	0 days	6	429.5	uV	66.11	161.94	electroretinography	cornea	subretinal injection	10	days	CHPG	b-wave amplitude ERG	108502	3123
RCS-rdy+ p+/LavRrrc	scotopic B wave amplitude of ERG waveform	phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-4.5 log(cd x m/s2))	Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z.	rod electrophysiology trait	both	0 days	6	101.1	uV	20.75	50.83	electroretinography	cornea	subretinal injection	10	days	pbs	b wave amplitude ERG	108506	3123
Hsd:SD	scotopic B wave amplitude of ERG waveform	gene transfer of the rat MER proto-oncogene, tyrosine kinase gene using an adenovirus vector (4 x 10E8 vg) then controlled exposure to darkness (for 12 hours) then visible light stimulus (5 cd/m2)	Conlon TJ, et al., Hum Gene Ther Clin Dev. 2013 Mar;24(1):23-8. doi: 10.1089/humc.2013.037. Epub 2013 Apr 3.	rod electrophysiology trait	both	0 days	9	387.0	uV			electroretinography	cornea	subretinal injection	30	days		scotopic b-wave ERG	108646	3128
Hsd:SD	scotopic B wave amplitude of ERG waveform	controlled exposure to darkness (for 12 hours) then visible light stimulus (5 cd/m2)	Conlon TJ, et al., Hum Gene Ther Clin Dev. 2013 Mar;24(1):23-8. doi: 10.1089/humc.2013.037. Epub 2013 Apr 3.	rod electrophysiology trait	both	0 days	9	488.0	uV			electroretinography	cornea		0			scotopic b-wave ERG	108647	3128
RCS/LavRrrc	scotopic B wave amplitude of ERG waveform	human periodontal ligament-derived stem cells (0.2 x 10E6 cells) then controlled exposure to darkness (for 12 hours) then visible light stimulus	Huang L, et al., Stem Cell Res Ther. 2017 Dec 22;8(1):290. doi: 10.1186/s13287-017-0731-y.	rod electrophysiology trait	not specified	49 days	4	204.9	uV	52.13	104.26	electroretinography	retina	hPDLSC transplant	28	days			109857	3157
RCS/LavRrrc	scotopic B wave amplitude of ERG waveform	controlled exposure to darkness (for 12 hours) then visible light stimulus	Huang L, et al., Stem Cell Res Ther. 2017 Dec 22;8(1):290. doi: 10.1186/s13287-017-0731-y.	rod electrophysiology trait	not specified	49 days	4	13.93	uV	1.49	2.98	electroretinography	retina	untreated control	28	days			109858	3157
RCS/LavRrrc	scotopic B wave amplitude of ERG waveform	vehicle control condition (2 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus	Huang L, et al., Stem Cell Res Ther. 2017 Dec 22;8(1):290. doi: 10.1186/s13287-017-0731-y.	rod electrophysiology trait	not specified	49 days	4	29.44	uV	7.44	14.87	electroretinography	retina	pbs vehicle injection	28	days			109859	3157
RCS-p+/LavRrrc	scotopic B wave amplitude of ERG waveform	gene transfer using empty plasmid vector pVAX2 (30 ug) then controlled exposure to darkness (for 1 days) then visible light stimulus (3 cd x s/m2)	Touchard E, et al., Gene Ther. 2012 Sep;19(9):886-98. doi: 10.1038/gt.2011.154. Epub 2011 Oct 13.	rod electrophysiology trait	both	53 days	5	352.0	uV	26.0	58.14	electroretinography	cornea	plasmid delivery	37	days		scotopic b-wave ERG	108728	3131
RCS-p+/LavRrrc	scotopic B wave amplitude of ERG waveform	2-methyl-6-(phenylethynyl)pyridine (200 umol) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-4.5 log(cd x m/s2))	Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z.	rod electrophysiology trait	both	39 days	7	7.44	uV	1.43	3.78	electroretinography	cornea	subretinal injection	4	days	pbs	a wave amplitude ERG	108542	3123
RCS-p+/LavRrrc	scotopic B wave amplitude of ERG waveform	2-methyl-6-(phenylethynyl)pyridine (200 umol) then controlled exposure to darkness (for 12 hours) then visible light stimulus (1 log(cd x m/s2))	Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z.	rod electrophysiology trait	both	39 days	7	251.29	uV	19.14	50.64	electroretinography	cornea	subretinal injection	4	days	pbs	a wave amplitude ERG	108547	3123
RCS-p+/LavRrrc	scotopic B wave amplitude of ERG waveform	gene transfer of the rat GDNF gene using the plasmid vector pVAX2 (30 ug) then controlled exposure to darkness (for 1 days) then visible light stimulus (3 cd x s/m2)	Touchard E, et al., Gene Ther. 2012 Sep;19(9):886-98. doi: 10.1038/gt.2011.154. Epub 2011 Oct 13.	rod electrophysiology trait	both	87 days	5	83.0	uV	7.0	15.65	electroretinography	cornea	plasmid delivery	71	days	pVAX2-rGDNF	scotopic b-wave ERG	108735	3131
RCS-rdy+ p+/LavRrrc	scotopic B wave amplitude of ERG waveform	DL-α-aminoadipate (70 ug/ul) and 2-methyl-6-(phenylethynyl)pyridine (200 umol) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-4.5 log(cd x m/s2))	Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z.	rod electrophysiology trait	both	0 days	6	119.08	uV	22.02	53.94	electroretinography	cornea	subretinal injection	2	days	dl-aaa + MPEP	b-wave amplitude ERG	108524	3123
RCS-rdy+ p+/LavRrrc	scotopic B wave amplitude of ERG waveform	DL-α-aminoadipate (70 ug/ul) and 2-methyl-6-(phenylethynyl)pyridine (200 umol) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-0.02 log(cd x m/s2))	Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z.	rod electrophysiology trait	both	0 days	6	739.67	uV	44.42	108.81	electroretinography	cornea	subretinal injection	2	days	dl-aaa + MPEP	b-wave amplitude ERG	108527	3123
RCS-rdy+ p+/LavRrrc	scotopic B wave amplitude of ERG waveform	DL-α-aminoadipate (70 ug/ul) and 2-methyl-6-(phenylethynyl)pyridine (200 umol) then controlled exposure to darkness (for 12 hours) then visible light stimulus (0.5 log(cd x m/s2))	Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z.	rod electrophysiology trait	both	0 days	6	748.17	uV	64.77	158.65	electroretinography	cornea	subretinal injection	2	days	dl-aaa + MPEP	b-wave amplitude ERG	108528	3123
RCS-rdy+ p+/LavRrrc	scotopic B wave amplitude of ERG waveform	DL-α-aminoadipate (70 ug/ul) and phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-0.02 log(cd x m/s2))	Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z.	rod electrophysiology trait	both	0 days	6	419.0	uV	21.83	53.47	electroretinography	cornea	subretinal injection	2	days	dl-aaa + pbs	b-wave amplitude ERG	108533	3123
RCS-rdy+ p+/LavRrrc	scotopic B wave amplitude of ERG waveform	DL-α-aminoadipate (70 ug/ul) and phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (0.5 log(cd x m/s2))	Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z.	rod electrophysiology trait	both	0 days	6	423.33	uV	25.5	62.46	electroretinography	cornea	subretinal injection	2	days	dl-aaa + pbs	b-wave amplitude ERG	108534	3123
Hsd:SD	scotopic B wave amplitude of ERG waveform	gene transfer of the rat MER proto-oncogene, tyrosine kinase gene using an adenovirus vector (40 x 10E8 vg) then controlled exposure to darkness (for 12 hours) then visible light stimulus (5 cd/m2)	Conlon TJ, et al., Hum Gene Ther Clin Dev. 2013 Mar;24(1):23-8. doi: 10.1089/humc.2013.037. Epub 2013 Apr 3.	rod electrophysiology trait	both	0 days	9	397.0	uV			electroretinography	cornea	subretinal injection	30	days		scotopic b-wave ERG	108652	3128
RCS/N	scotopic B wave amplitude of ERG waveform	control condition then controlled exposure to darkness (for 12 hours) then visible light stimulus (2.5 cd x s/m2)	Deng WT, et al., Invest Ophthalmol Vis Sci. 2012 Apr 6;53(4):1895-904. doi: 10.1167/iovs.11-8831.	rod electrophysiology trait	not specified	62 days	6	61.0	uV	19.6	48.0	electroretinography	cornea	AAV8 injection	60	days	contralateral control eye	scotopic b-wave amplitude ERG	108683	3129
RCS-p+/LavRrrc	scotopic B wave amplitude of ERG waveform	control condition then controlled exposure to darkness (for 1 days) then visible light stimulus (3 cd x s/m2)	Touchard E, et al., Gene Ther. 2012 Sep;19(9):886-98. doi: 10.1038/gt.2011.154. Epub 2011 Oct 13.	rod electrophysiology trait	both	75 days	5	24.7	uV	13.8	30.86	electroretinography	cornea		59	days	control for age matched plasmid injection	scotopic b-wave ERG	108704	3131
RCS-p+/LavRrrc	scotopic B wave amplitude of ERG waveform	gene transfer using empty plasmid vector pVAX2 (30 ug) and gene transfer using empty plasmid vector pVAX2 (30 ug) then controlled exposure to darkness (for 1 days) then visible light stimulus (3 cd x s/m2)	Touchard E, et al., Gene Ther. 2012 Sep;19(9):886-98. doi: 10.1038/gt.2011.154. Epub 2011 Oct 13.	rod electrophysiology trait	both	70 days	3	231.0	uV	5.0	8.66	electroretinography	cornea	plasmid delivery	54	days	pVAX2	scotopic b-wave ERG	108749	3131
RCS-p+/LavRrrc	scotopic B wave amplitude of ERG waveform	gene transfer of the rat GDNF gene using the plasmid vector pVAX2 (15 ug) and gene transfer of the rat GDNF gene using the plasmid vector pVAX2 (15 ug) then controlled exposure to darkness (for 1 days) then visible light stimulus (3 cd x s/m2)	Touchard E, et al., Gene Ther. 2012 Sep;19(9):886-98. doi: 10.1038/gt.2011.154. Epub 2011 Oct 13.	rod electrophysiology trait	both	70 days	3	199.0	uV	17.0	29.44	electroretinography	cornea	plasmid delivery	54	days	pVAX2-rGDNF	scotopic b-wave ERG	108750	3131
RCS-p+/LavRrrc	scotopic B wave amplitude of ERG waveform	control condition then controlled exposure to darkness (for 12 hours)	Tao Z, et al., Oncotarget. 2016 Aug 2;7(31):49368-49383. doi: 10.18632/oncotarget.10343.	rod electrophysiology trait	both	62 days	5	13.0	uV	17.0	38.01	electroretinography			0		untreated control	b-wave amplitude ERG	108389	3121
RCS-rdy+ p+/LavRrrc	scotopic B wave amplitude of ERG waveform	DL-α-aminoadipate (70 ug/ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-2.5 log(cd x m/s2))	Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z.	rod electrophysiology trait	both	0 days	6	327.83	uV	16.41	40.2	electroretinography	cornea	subretinal injection	7	days	dl-aaa	b-wave amplitude ERG	108405	3123
RCS-rdy+ p+/LavRrrc	scotopic B wave amplitude of ERG waveform	phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-0.5 log(cd x m/s2))	Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z.	rod electrophysiology trait	both	0 days	6	532.5	uV	62.77	153.75	electroretinography	cornea	subretinal injection	7	days	dl-aaa	b-wave amplitude ERG	108412	3123
RCS-rdy+ p+/LavRrrc	scotopic B wave amplitude of ERG waveform	2-Chloro-5-hydroxyphenylglycine (200 umol) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-0.5 log(cd x m/s2))	Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z.	rod electrophysiology trait	both	0 days	6	440.0	uV	43.67	106.97	electroretinography	cornea	subretinal injection	30	min	CHPG	b-wave amplitude ERG	108454	3123
RCS-rdy+ p+/LavRrrc	scotopic B wave amplitude of ERG waveform	2-Chloro-5-hydroxyphenylglycine (200 umol) then controlled exposure to darkness (for 12 hours) then visible light stimulus (1 log(cd x m/s2))	Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z.	rod electrophysiology trait	both	0 days	6	579.0	uV	50.99	124.9	electroretinography	cornea	subretinal injection	30	min	CHPG	b-wave amplitude ERG	108457	3123
RCS-rdy+ p+/LavRrrc	scotopic B wave amplitude of ERG waveform	phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-2.5 log(cd x m/s2))	Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z.	rod electrophysiology trait	both	0 days	6	358.5	uV	35.71	87.47	electroretinography	cornea	subretinal injection	30	min	pbs	b-wave amplitude ERG	108459	3123
RCS-rdy+ p+/LavRrrc	scotopic B wave amplitude of ERG waveform	phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (0.5 log(cd x m/s2))	Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z.	rod electrophysiology trait	both	0 days	6	584.5	uV	38.15	93.45	electroretinography	cornea	subretinal injection	30	min	pbs	b-wave amplitude ERG	108462	3123
RCS-rdy+ p+/LavRrrc	scotopic B wave amplitude of ERG waveform	2-Chloro-5-hydroxyphenylglycine (200 umol) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-0.02 log(cd x m/s2))	Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z.	rod electrophysiology trait	both	0 days	11	351.91	uV	47.74	158.34	electroretinography	cornea	subretinal injection	2	days	CHPG	b-wave amplitude ERG	108479	3123
RCS-rdy+ p+/LavRrrc	scotopic B wave amplitude of ERG waveform	2-Chloro-5-hydroxyphenylglycine (200 umol) then controlled exposure to darkness (for 12 hours) then visible light stimulus (0.5 log(cd x m/s2))	Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z.	rod electrophysiology trait	both	0 days	11	389.91	uV	52.11	172.83	electroretinography	cornea	subretinal injection	2	days	CHPG	b-wave amplitude ERG	108480	3123
RCS-rdy+ p+/LavRrrc	scotopic B wave amplitude of ERG waveform	phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-2.5 log(cd x m/s2))	Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z.	rod electrophysiology trait	both	0 days	11	410.45	uV	48.4	160.52	electroretinography	cornea	subretinal injection	2	days	pbs	b wave amplitude ERG	108483	3123
RCS-rdy+ p+/LavRrrc	scotopic B wave amplitude of ERG waveform	2-Chloro-5-hydroxyphenylglycine (200 umol) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-4.5 log(cd x m/s2))	Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z.	rod electrophysiology trait	both	0 days	6	71.98	uV	18.54	45.41	electroretinography	cornea	subretinal injection	10	days	CHPG	b-wave amplitude ERG	108500	3123
Hsd:SD	scotopic B wave amplitude of ERG waveform	controlled exposure to darkness (for 12 hours) then visible light stimulus (5 cd/m2)	Conlon TJ, et al., Hum Gene Ther Clin Dev. 2013 Mar;24(1):23-8. doi: 10.1089/humc.2013.037. Epub 2013 Apr 3.	rod electrophysiology trait	both	0 days	9	491.0	uV			electroretinography	cornea		0			scotopic b-wave ERG	108653	3128
RCS/LavRrrc	scotopic B wave amplitude of ERG waveform	vehicle control condition (2 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus	Huang L, et al., Stem Cell Res Ther. 2017 Dec 22;8(1):290. doi: 10.1186/s13287-017-0731-y.	rod electrophysiology trait	not specified	35 days	4	95.22	uV	16.19	32.38	electroretinography	retina	pbs vehicle injection	14	days			109856	3157
RCS/LavRrrc	scotopic B wave amplitude of ERG waveform	vehicle control condition (2 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus	Huang L, et al., Stem Cell Res Ther. 2017 Dec 22;8(1):290. doi: 10.1186/s13287-017-0731-y.	rod electrophysiology trait	not specified	77 days	4	13.01	uV	1.85	3.69	electroretinography	retina	pbs vehicle injection	56	days			109862	3157
RCS/N	scotopic B wave amplitude of ERG waveform	gene transfer of the rat MER proto-oncogene, tyrosine kinase gene using an adenovirus vector (21.6 x 10E8 vg) then controlled exposure to darkness (for 12 hours) then visible light stimulus (2.5 cd x s/m2)	Deng WT, et al., Invest Ophthalmol Vis Sci. 2012 Apr 6;53(4):1895-904. doi: 10.1167/iovs.11-8831.	rod electrophysiology trait	not specified	62 days	6	500.0	uV	61.24	150.0	electroretinography	cornea	AAV8 injection	60	days	treated eye	scotopic b-wave amplitude ERG	108682	3129
RCS/N	scotopic B wave amplitude of ERG waveform	lensotomy then controlled exposure to darkness (for 1 days) then visible light stimulus (100 cd x s/m2)	Heiduschka P, et al., ISRN Ophthalmol. 2013 Sep 19;2013:814814. doi: 10.1155/2013/814814. eCollection 2013.	rod electrophysiology trait	not specified	60 days	3	30.5	uV	7.51	13.0	electroretinography	cornea	lens puncture	30	days		scotopic b-wave ERG	108567	3124
RCS-p+/LavRrrc	scotopic B wave amplitude of ERG waveform	2-methyl-6-(phenylethynyl)pyridine (200 umol) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-0.02 log(cd x m/s2))	Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z.	rod electrophysiology trait	both	39 days	7	192.0	uV	14.42	38.15	electroretinography	cornea	subretinal injection	4	days	pbs	a wave amplitude ERG	108545	3123
RCS-p+/LavRrrc	scotopic B wave amplitude of ERG waveform	phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-0.5 log(cd x m/s2))	Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z.	rod electrophysiology trait	both	39 days	7	94.13	uV	15.33	40.56	electroretinography	cornea	subretinal injection	4	days	pbs	b-wave amplitude ERG	108556	3123
RCS-p+/LavRrrc	scotopic B wave amplitude of ERG waveform	phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (1 log(cd x m/s2))	Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z.	rod electrophysiology trait	both	39 days	7	179.49	uV	20.75	54.9	electroretinography	cornea	subretinal injection	4	days	pbs	b-wave amplitude ERG	108559	3123
RCS/LavRrrc	scotopic B wave amplitude of ERG waveform	controlled exposure to darkness (for 12 hours) then visible light stimulus	Huang L, et al., Stem Cell Res Ther. 2017 Dec 22;8(1):290. doi: 10.1186/s13287-017-0731-y.	rod electrophysiology trait	not specified	77 days	4	12.57	uV	1.42	2.84	electroretinography	retina	untreated control	56	days			109861	3157
RCS-rdy+ p+/LavRrrc	scotopic B wave amplitude of ERG waveform	DL-α-aminoadipate (70 ug/ul) and phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-4.5 log(cd x m/s2))	Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z.	rod electrophysiology trait	both	0 days	6	47.53	uV	9.4	23.03	electroretinography	cornea	subretinal injection	2	days	dl-aaa + pbs	b-wave amplitude ERG	108530	3123
RCS-rdy+ p+/LavRrrc	scotopic B wave amplitude of ERG waveform	DL-α-aminoadipate (70 ug/ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-4.5 log(cd x m/s2))	Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z.	rod electrophysiology trait	both	0 days	6	65.42	uV	13.87	33.97	electroretinography	cornea	subretinal injection	10	days	dl-aaa	b-wave amplitude ERG	108428	3123
RCS-rdy+ p+/LavRrrc	scotopic B wave amplitude of ERG waveform	DL-α-aminoadipate (70 ug/ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-0.5 log(cd x m/s2))	Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z.	rod electrophysiology trait	both	0 days	6	382.17	uV	30.52	74.76	electroretinography	cornea	subretinal injection	10	days	dl-aaa	b-wave amplitude ERG	108430	3123
RCS-rdy+ p+/LavRrrc	scotopic B wave amplitude of ERG waveform	DL-α-aminoadipate (70 ug/ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (0.5 log(cd x m/s2))	Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z.	rod electrophysiology trait	both	0 days	6	519.33	uV	29.94	73.34	electroretinography	cornea	subretinal injection	10	days	dl-aaa	b-wave amplitude ERG	108432	3123
RCS-rdy+ p+/LavRrrc	scotopic B wave amplitude of ERG waveform	phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (0.5 log(cd x m/s2))	Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z.	rod electrophysiology trait	both	0 days	6	570.67	uV	21.08	51.64	electroretinography	cornea	subretinal injection	10	days	dl-aaa	b-wave amplitude ERG	108438	3123
RCS-rdy+ p+/LavRrrc	scotopic B wave amplitude of ERG waveform	phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (1 log(cd x m/s2))	Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z.	rod electrophysiology trait	both	0 days	6	621.67	uV	35.23	86.3	electroretinography	cornea	subretinal injection	10	days	dl-aaa	b-wave amplitude ERG	108439	3123
RCS-rdy+ p+/LavRrrc	scotopic B wave amplitude of ERG waveform	2-Chloro-5-hydroxyphenylglycine (200 umol) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-0.02 log(cd x m/s2))	Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z.	rod electrophysiology trait	both	0 days	6	514.67	uV	47.85	117.21	electroretinography	cornea	subretinal injection	30	min	CHPG	b-wave amplitude ERG	108455	3123
RCS-rdy+ p+/LavRrrc	scotopic B wave amplitude of ERG waveform	phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-4.5 log(cd x m/s2))	Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z.	rod electrophysiology trait	both	0 days	6	49.97	uV	12.07	29.57	electroretinography	cornea	subretinal injection	30	min	pbs	b-wave amplitude ERG	108458	3123
RCS-rdy+ p+/LavRrrc	scotopic B wave amplitude of ERG waveform	phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-0.5 log(cd x m/s2))	Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z.	rod electrophysiology trait	both	0 days	6	438.83	uV	24.27	59.45	electroretinography	cornea	subretinal injection	30	min	pbs	b-wave amplitude ERG	108460	3123
RCS-rdy+ p+/LavRrrc	scotopic B wave amplitude of ERG waveform	2-Chloro-5-hydroxyphenylglycine (200 umol) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-0.5 log(cd x m/s2))	Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z.	rod electrophysiology trait	both	0 days	11	334.55	uV	43.36	143.81	electroretinography	cornea	subretinal injection	2	days	CHPG	b-wave amplitude ERG	108478	3123
RCS-rdy+ p+/LavRrrc	scotopic B wave amplitude of ERG waveform	2-Chloro-5-hydroxyphenylglycine (200 umol) then controlled exposure to darkness (for 12 hours) then visible light stimulus (1 log(cd x m/s2))	Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z.	rod electrophysiology trait	both	0 days	11	410.09	uV	45.37	150.48	electroretinography	cornea	subretinal injection	2	days	CHPG	b-wave amplitude ERG	108481	3123
RCS-rdy+ p+/LavRrrc	scotopic B wave amplitude of ERG waveform	2-Chloro-5-hydroxyphenylglycine (200 umol) then controlled exposure to darkness (for 12 hours) then visible light stimulus (1 log(cd x m/s2))	Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z.	rod electrophysiology trait	both	0 days	6	605.83	uV	62.69	153.56	electroretinography	cornea	subretinal injection	10	days	CHPG	b-wave amplitude ERG	108505	3123
RCS-rdy+ p+/LavRrrc	scotopic B wave amplitude of ERG waveform	phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-2.5 log(cd x m/s2))	Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z.	rod electrophysiology trait	both	0 days	6	393.0	uV	65.49	160.42	electroretinography	cornea	subretinal injection	10	days	pbs	b wave amplitude ERG	108507	3123
RCS-p+/LavRrrc	scotopic B wave amplitude of ERG waveform	control condition then controlled exposure to darkness (for 12 hours)	Tao Z, et al., Oncotarget. 2016 Aug 2;7(31):49368-49383. doi: 10.18632/oncotarget.10343.	rod electrophysiology trait	both	34 days	8	45.0	uV	42.0	118.79	electroretinography			0		untreated control	b-wave amplitude ERG	108377	3121
RCS-p+/LavRrrc	scotopic B wave amplitude of ERG waveform	gene transfer of the enhanced green fluorescent protein gene using an adenovirus vector (5250000 PFU) then controlled exposure to darkness (for 12 hours)	Tao Z, et al., Oncotarget. 2016 Aug 2;7(31):49368-49383. doi: 10.18632/oncotarget.10343.	rod electrophysiology trait	both	62 days	5	14.0	uV	17.0	38.01	electroretinography	cornea	subretinal injection	42	days	adenovirus	b-wave amplitude ERG	108390	3121
RCS-p+/LavRrrc	scotopic B wave amplitude of ERG waveform	gene transfer of the lin-28 homolog B gene using an adenovirus vector (5250000 PFU) then controlled exposure to darkness (for 12 hours)	Tao Z, et al., Oncotarget. 2016 Aug 2;7(31):49368-49383. doi: 10.18632/oncotarget.10343.	rod electrophysiology trait	both	62 days	5	34.0	uV	27.0	60.37	electroretinography	cornea	subretinal injection	42	days	adenovirus	b-wave amplitude ERG	108391	3121
RCS-rdy+ p+/LavRrrc	scotopic B wave amplitude of ERG waveform	DL-α-aminoadipate (70 ug/ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-4.5 log(cd x m/s2))	Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z.	rod electrophysiology trait	both	0 days	6	51.68	uV	12.61	30.89	electroretinography	cornea	subretinal injection	7	days	dl-aaa	b-wave amplitude ERG	108404	3123
RCS-p+/LavRrrc	scotopic B wave amplitude of ERG waveform	gene transfer of the rat GDNF gene using the plasmid vector pVAX2 (30 ug) then controlled exposure to darkness (for 1 days) then visible light stimulus (3 cd x s/m2)	Touchard E, et al., Gene Ther. 2012 Sep;19(9):886-98. doi: 10.1038/gt.2011.154. Epub 2011 Oct 13.	rod electrophysiology trait	both	53 days	5	475.0	uV	41.0	91.68	electroretinography	cornea	plasmid delivery	37	days	pVAX2-rGDNF	scotopic b-wave ERG	108727	3131
RCS-p+/LavRrrc	scotopic B wave amplitude of ERG waveform	gene transfer of the rat GDNF gene using the plasmid vector pVAX2 (30 ug) then controlled exposure to darkness (for 1 days) then visible light stimulus (3 cd x s/m2)	Touchard E, et al., Gene Ther. 2012 Sep;19(9):886-98. doi: 10.1038/gt.2011.154. Epub 2011 Oct 13.	rod electrophysiology trait	both	75 days	5	135.0	uV	38.0	84.97	electroretinography	cornea	plasmid delivery	59	days	pVAX2-rGDNF	scotopic b-wave ERG	108731	3131
RCS-p+/LavRrrc	scotopic B wave amplitude of ERG waveform	phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (0.5 log(cd x m/s2))	Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z.	rod electrophysiology trait	both	39 days	7	159.83	uV	21.35	56.49	electroretinography	cornea	subretinal injection	4	days	pbs	b-wave amplitude ERG	108558	3123
RCS/LavRrrc	scotopic B wave amplitude of ERG waveform	controlled exposure to darkness (for 12 hours) then visible light stimulus	Huang L, et al., Stem Cell Res Ther. 2017 Dec 22;8(1):290. doi: 10.1186/s13287-017-0731-y.	rod electrophysiology trait	not specified	35 days	4	61.63	uV	15.09	30.17	electroretinography	retina	untreated control	14	days			109855	3157
RCS/LavRrrc	scotopic B wave amplitude of ERG waveform	human periodontal ligament-derived stem cells (0.2 x 10E6 cells) then controlled exposure to darkness (for 12 hours) then visible light stimulus	Huang L, et al., Stem Cell Res Ther. 2017 Dec 22;8(1):290. doi: 10.1186/s13287-017-0731-y.	rod electrophysiology trait	not specified	77 days	4	45.89	uV	3.23	6.45	electroretinography	retina	hPDLSC transplant	56	days			109860	3157
RCS-rdy+ p+/LavRrrc	scotopic B wave amplitude of ERG waveform	DL-α-aminoadipate (70 ug/ul) and phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (1 log(cd x m/s2))	Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z.	rod electrophysiology trait	both	0 days	6	455.17	uV	35.54	87.05	electroretinography	cornea	subretinal injection	2	days	dl-aaa + pbs	b-wave amplitude ERG	108535	3123
RCS-p+/LavRrrc	scotopic B wave amplitude of ERG waveform	gene transfer using empty plasmid vector pVAX2 (30 ug) then controlled exposure to darkness (for 1 days) then visible light stimulus (3 cd x s/m2)	Touchard E, et al., Gene Ther. 2012 Sep;19(9):886-98. doi: 10.1038/gt.2011.154. Epub 2011 Oct 13.	rod electrophysiology trait	both	87 days	5	110.0	uV	14.0	31.3	electroretinography	cornea	plasmid delivery	71	days		scotopic b-wave ERG	108736	3131
RCS-p+/LavRrrc	scotopic B wave amplitude of ERG waveform	gene transfer of the rat GDNF gene using the plasmid vector pVAX2 (30 ug) and gene transfer of the rat GDNF gene using the plasmid vector pVAX2 (30 ug) then controlled exposure to darkness (for 1 days) then visible light stimulus (3 cd x s/m2)	Touchard E, et al., Gene Ther. 2012 Sep;19(9):886-98. doi: 10.1038/gt.2011.154. Epub 2011 Oct 13.	rod electrophysiology trait	both	70 days	3	144.0	uV	29.0	50.23	electroretinography	cornea	plasmid delivery	54	days	pVAX2-rGDNF	scotopic b-wave ERG	108751	3131
RCS-rdy+ p+/LavRrrc	scotopic B wave amplitude of ERG waveform	phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (0.5 log(cd x m/s2))	Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z.	rod electrophysiology trait	both	0 days	6	570.67	uV	53.5	131.05	electroretinography	cornea	subretinal injection	10	days	pbs	b wave amplitude ERG	108510	3123
RCS-rdy+ p+/LavRrrc	scotopic B wave amplitude of ERG waveform	phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (1 log(cd x m/s2))	Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z.	rod electrophysiology trait	both	0 days	6	625.0	uV	55.4	135.7	electroretinography	cornea	subretinal injection	10	days	pbs	b wave amplitude ERG	108511	3123
RCS-rdy+ p+/LavRrrc	scotopic B wave amplitude of ERG waveform	DL-α-aminoadipate (70 ug/ul) and 2-methyl-6-(phenylethynyl)pyridine (200 umol) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-2.5 log(cd x m/s2))	Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z.	rod electrophysiology trait	both	0 days	6	584.5	uV	55.51	135.97	electroretinography	cornea	subretinal injection	2	days	dl-aaa + MPEP	b-wave amplitude ERG	108525	3123
RCS-rdy+ p+/LavRrrc	scotopic B wave amplitude of ERG waveform	DL-α-aminoadipate (70 ug/ul) and 2-methyl-6-(phenylethynyl)pyridine (200 umol) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-0.5 log(cd x m/s2))	Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z.	rod electrophysiology trait	both	0 days	6	644.33	uV	50.52	123.75	electroretinography	cornea	subretinal injection	2	days	dl-aaa + MPEP	b-wave amplitude ERG	108526	3123
RCS-rdy+ p+/LavRrrc	scotopic B wave amplitude of ERG waveform	DL-α-aminoadipate (70 ug/ul) and phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-2.5 log(cd x m/s2))	Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z.	rod electrophysiology trait	both	0 days	6	354.0	uV	16.81	41.18	electroretinography	cornea	subretinal injection	2	days	dl-aaa + pbs	b-wave amplitude ERG	108531	3123
RCS-rdy+ p+/LavRrrc	scotopic B wave amplitude of ERG waveform	DL-α-aminoadipate (70 ug/ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-0.5 log(cd x m/s2))	Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z.	rod electrophysiology trait	both	0 days	6	371.67	uV	28.82	70.59	electroretinography	cornea	subretinal injection	7	days	dl-aaa	b-wave amplitude ERG	108406	3123
RCS-rdy+ p+/LavRrrc	scotopic B wave amplitude of ERG waveform	DL-α-aminoadipate (70 ug/ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-0.02 log(cd x m/s2))	Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z.	rod electrophysiology trait	both	0 days	6	391.5	uV	33.43	81.89	electroretinography	cornea	subretinal injection	7	days	dl-aaa	b-wave amplitude ERG	108407	3123
RCS-rdy+ p+/LavRrrc	scotopic B wave amplitude of ERG waveform	phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-4.5 log(cd x m/s2))	Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z.	rod electrophysiology trait	both	0 days	6	42.97	uV	8.99	22.02	electroretinography	cornea	subretinal injection	10	days	dl-aaa	b-wave amplitude ERG	108434	3123
RCS-rdy+ p+/LavRrrc	scotopic B wave amplitude of ERG waveform	phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-0.5 log(cd x m/s2))	Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z.	rod electrophysiology trait	both	0 days	6	399.83	uV	37.74	92.44	electroretinography	cornea	subretinal injection	10	days	dl-aaa	b-wave amplitude ERG	108436	3123
RCS-rdy+ p+/LavRrrc	scotopic B wave amplitude of ERG waveform	2-Chloro-5-hydroxyphenylglycine (200 umol) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-4.5 log(cd x m/s2))	Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z.	rod electrophysiology trait	both	0 days	6	56.16	uV	17.2	42.13	electroretinography	cornea	subretinal injection	30	min	CHPG	b-wave amplitude ERG	108452	3123
RCS-rdy+ p+/LavRrrc	scotopic B wave amplitude of ERG waveform	2-Chloro-5-hydroxyphenylglycine (200 umol) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-2.5 log(cd x m/s2))	Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z.	rod electrophysiology trait	both	0 days	6	381.17	uV	37.99	93.06	electroretinography	cornea	subretinal injection	30	min	CHPG	b-wave amplitude ERG	108453	3123
RCS-rdy+ p+/LavRrrc	scotopic B wave amplitude of ERG waveform	2-Chloro-5-hydroxyphenylglycine (200 umol) then controlled exposure to darkness (for 12 hours) then visible light stimulus (0.5 log(cd x m/s2))	Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z.	rod electrophysiology trait	both	0 days	6	587.83	uV	53.2	130.31	electroretinography	cornea	subretinal injection	30	min	CHPG	b-wave amplitude ERG	108456	3123
RCS-rdy+ p+/LavRrrc	scotopic B wave amplitude of ERG waveform	phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (1 log(cd x m/s2))	Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z.	rod electrophysiology trait	both	0 days	11	607.73	uV	58.9	195.35	electroretinography	cornea	subretinal injection	2	days	pbs	b wave amplitude ERG	108487	3123
RCS-rdy+ p+/LavRrrc	scotopic B wave amplitude of ERG waveform	2-Chloro-5-hydroxyphenylglycine (200 umol) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-0.02 log(cd x m/s2))	Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z.	rod electrophysiology trait	both	0 days	6	485.67	uV	73.15	179.18	electroretinography	cornea	subretinal injection	10	days	CHPG	b-wave amplitude ERG	108503	3123
RCS-rdy+ p+/LavRrrc	scotopic B wave amplitude of ERG waveform	2-Chloro-5-hydroxyphenylglycine (200 umol) then controlled exposure to darkness (for 12 hours) then visible light stimulus (0.5 log(cd x m/s2))	Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z.	rod electrophysiology trait	both	0 days	6	511.83	uV	65.06	159.36	electroretinography	cornea	subretinal injection	10	days	CHPG	b-wave amplitude ERG	108504	3123
RCS-rdy+ p+/LavRrrc	scotopic B wave amplitude of ERG waveform	phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-0.02 log(cd x m/s2))	Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z.	rod electrophysiology trait	both	0 days	6	587.17	uV	49.54	121.35	electroretinography	cornea	subretinal injection	10	days	pbs	b wave amplitude ERG	108509	3123
RCS-p+/LavRrrc	scotopic B wave amplitude of ERG waveform	gene transfer of the lin-28 homolog B gene using an adenovirus vector (5250000 PFU) then controlled exposure to darkness (for 12 hours)	Tao Z, et al., Oncotarget. 2016 Aug 2;7(31):49368-49383. doi: 10.18632/oncotarget.10343.	rod electrophysiology trait	both	48 days	5	110.0	uV	40.0	89.44	electroretinography	cornea	subretinal injection	28	days	adenovirus	b-wave amplitude ERG	108385	3121
RCS-p+/LavRrrc	scotopic B wave amplitude of ERG waveform	gene transfer using empty plasmid vector pVAX2 (30 ug) then controlled exposure to darkness (for 1 days) then visible light stimulus (3 cd x s/m2)	Touchard E, et al., Gene Ther. 2012 Sep;19(9):886-98. doi: 10.1038/gt.2011.154. Epub 2011 Oct 13.	rod electrophysiology trait	both	75 days	5	114.0	uV	16.0	35.78	electroretinography	cornea	plasmid delivery	59	days		scotopic b-wave ERG	108732	3131
RCS-p+/LavRrrc	scotopic B wave amplitude of ERG waveform	2-methyl-6-(phenylethynyl)pyridine (200 umol) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-0.5 log(cd x m/s2))	Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z.	rod electrophysiology trait	both	39 days	7	145.24	uV	12.56	33.23	electroretinography	cornea	subretinal injection	4	days	pbs	a wave amplitude ERG	108544	3123
RCS-p+/LavRrrc	scotopic B wave amplitude of ERG waveform	phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-2.5 log(cd x m/s2))	Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z.	rod electrophysiology trait	both	39 days	7	32.75	uV	13.42	35.51	electroretinography	cornea	subretinal injection	4	days	pbs	b-wave amplitude ERG	108555	3123
RCS-p+/LavRrrc	scotopic B wave amplitude of ERG waveform	phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-0.02 log(cd x m/s2))	Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z.	rod electrophysiology trait	both	39 days	7	131.7	uV	16.13	42.68	electroretinography	cornea	subretinal injection	4	days	pbs	b-wave amplitude ERG	108557	3123
RCS-p+/LavRrrc	scotopic B wave amplitude of ERG waveform	gene transfer of the enhanced green fluorescent protein gene using an adenovirus vector (5250000 PFU) then controlled exposure to darkness (for 12 hours)	Tao Z, et al., Oncotarget. 2016 Aug 2;7(31):49368-49383. doi: 10.18632/oncotarget.10343.	rod electrophysiology trait	both	48 days	5	51.0	uV	33.0	73.79	electroretinography	cornea	subretinal injection	28	days	adenovirus	b-wave amplitude ERG	108384	3121
RCS-rdy+ p+/LavRrrc	scotopic B wave amplitude of ERG waveform	DL-α-aminoadipate (70 ug/ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (1 log(cd x m/s2))	Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z.	rod electrophysiology trait	both	0 days	6	430.17	uV	45.59	111.67	electroretinography	cornea	subretinal injection	7	days	dl-aaa	b-wave amplitude ERG	108409	3123
RCS-rdy+ p+/LavRrrc	scotopic B wave amplitude of ERG waveform	phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-2.5 log(cd x m/s2))	Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z.	rod electrophysiology trait	both	0 days	6	460.67	uV	47.48	116.3	electroretinography	cornea	subretinal injection	7	days	dl-aaa	b-wave amplitude ERG	108411	3123
RCS-rdy+ p+/LavRrrc	scotopic B wave amplitude of ERG waveform	phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-0.02 log(cd x m/s2))	Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z.	rod electrophysiology trait	both	0 days	6	592.83	uV	68.9	168.77	electroretinography	cornea	subretinal injection	7	days	dl-aaa	b-wave amplitude ERG	108413	3123
RCS-rdy+ p+/LavRrrc	scotopic B wave amplitude of ERG waveform	phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (0.5 log(cd x m/s2))	Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z.	rod electrophysiology trait	both	0 days	6	638.33	uV	68.2	167.06	electroretinography	cornea	subretinal injection	7	days	dl-aaa	b-wave amplitude ERG	108414	3123
RCS-rdy+ p+/LavRrrc	scotopic B wave amplitude of ERG waveform	phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-2.5 log(cd x m/s2))	Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z.	rod electrophysiology trait	both	0 days	6	356.17	uV	23.35	57.2	electroretinography	cornea	subretinal injection	10	days	dl-aaa	b-wave amplitude ERG	108435	3123
RCS-rdy+ p+/LavRrrc	scotopic B wave amplitude of ERG waveform	phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-0.02 log(cd x m/s2))	Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z.	rod electrophysiology trait	both	0 days	6	497.33	uV	42.65	104.47	electroretinography	cornea	subretinal injection	10	days	dl-aaa	b-wave amplitude ERG	108437	3123
RCS-rdy+ p+/LavRrrc	scotopic B wave amplitude of ERG waveform	phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-0.02 log(cd x m/s2))	Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z.	rod electrophysiology trait	both	0 days	6	516.5	uV	29.8	72.99	electroretinography	cornea	subretinal injection	30	min	pbs	b-wave amplitude ERG	108461	3123
RCS-rdy+ p+/LavRrrc	scotopic B wave amplitude of ERG waveform	2-Chloro-5-hydroxyphenylglycine (200 umol) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-4.5 log(cd x m/s2))	Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z.	rod electrophysiology trait	both	0 days	11	44.02	uV	13.47	44.67	electroretinography	cornea	subretinal injection	2	days	CHPG	b-wave amplitude ERG	108476	3123
RCS-rdy+ p+/LavRrrc	scotopic B wave amplitude of ERG waveform	phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-4.5 log(cd x m/s2))	Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z.	rod electrophysiology trait	both	0 days	11	56.72	uV	16.42	54.46	electroretinography	cornea	subretinal injection	2	days	pbs	b wave amplitude ERG	108482	3123
RCS-rdy+ p+/LavRrrc	scotopic B wave amplitude of ERG waveform	phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (0.5 log(cd x m/s2))	Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z.	rod electrophysiology trait	both	0 days	11	567.73	uV	56.78	188.32	electroretinography	cornea	subretinal injection	2	days	pbs	b wave amplitude ERG	108486	3123
RCS-rdy+ p+/LavRrrc	scotopic B wave amplitude of ERG waveform	phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-0.5 log(cd x m/s2))	Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z.	rod electrophysiology trait	both	0 days	6	533.17	uV	67.99	166.54	electroretinography	cornea	subretinal injection	10	days	pbs	b wave amplitude ERG	108508	3123
RCS-rdy+ p+/LavRrrc	scotopic B wave amplitude of ERG waveform	DL-α-aminoadipate (70 ug/ul) and 2-methyl-6-(phenylethynyl)pyridine (200 umol) then controlled exposure to darkness (for 12 hours) then visible light stimulus (1 log(cd x m/s2))	Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z.	rod electrophysiology trait	both	0 days	6	800.0	uV	67.71	165.85	electroretinography	cornea	subretinal injection	2	days	dl-aaa + MPEP	b-wave amplitude ERG	108529	3123
RCS-rdy+ p+/LavRrrc	scotopic B wave amplitude of ERG waveform	DL-α-aminoadipate (70 ug/ul) and phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-0.5 log(cd x m/s2))	Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z.	rod electrophysiology trait	both	0 days	6	382.33	uV	22.98	56.29	electroretinography	cornea	subretinal injection	2	days	dl-aaa + pbs	b-wave amplitude ERG	108532	3123
RCS-p+/LavRrrc	scotopic B wave amplitude of ERG waveform	gene transfer using empty plasmid vector pVAX2 (30 ug) then controlled exposure to darkness (for 1 days) then visible light stimulus (3 cd x s/m2)	Touchard E, et al., Gene Ther. 2012 Sep;19(9):886-98. doi: 10.1038/gt.2011.154. Epub 2011 Oct 13.	rod electrophysiology trait	both	53 days	5	352.0	uV	26.0	58.14	electroretinography	cornea	plasmid delivery	37	days		scotopic b-wave ERG	108701	3131
RCS-p+/LavRrrc	scotopic B wave amplitude of ERG waveform	control condition then controlled exposure to darkness (for 1 days) then visible light stimulus (3 cd x s/m2)	Touchard E, et al., Gene Ther. 2012 Sep;19(9):886-98. doi: 10.1038/gt.2011.154. Epub 2011 Oct 13.	rod electrophysiology trait	both	53 days	5	186.0	uV	23.8	53.22	electroretinography	cornea		37	days	control for age matched plasmid injection	scotopic b-wave ERG	108702	3131
RCS-p+/LavRrrc	scotopic B wave amplitude of ERG waveform	gene transfer of the enhanced green fluorescent protein gene using an adenovirus vector (5250000 PFU) then controlled exposure to darkness (for 12 hours)	Tao Z, et al., Oncotarget. 2016 Aug 2;7(31):49368-49383. doi: 10.18632/oncotarget.10343.	rod electrophysiology trait	both	34 days	8	39.0	uV	23.0	65.05	electroretinography	cornea	subretinal injection	14	days	adenovirus	b-wave amplitude ERG	108378	3121
RCS/N	scotopic B wave amplitude of ERG waveform	gene transfer of the rat MER proto-oncogene, tyrosine kinase gene using an adenovirus vector (21.6 x 10E8 vg) then controlled exposure to darkness (for 12 hours) then visible light stimulus (0.01 cd x s/m2)	Deng WT, et al., Invest Ophthalmol Vis Sci. 2012 Apr 6;53(4):1895-904. doi: 10.1167/iovs.11-8831.	rod electrophysiology trait	not specified	242 days	4	223.0	uV	28.0	56.0	electroretinography	cornea	AAV8 injection	240	days	treated eye	scotopic b-wave amplitude ERG	108684	3129
RCS/LavRrrc	scotopic B wave amplitude of ERG waveform	human periodontal ligament-derived stem cells (0.2 x 10E6 cells) then controlled exposure to darkness (for 12 hours) then visible light stimulus	Huang L, et al., Stem Cell Res Ther. 2017 Dec 22;8(1):290. doi: 10.1186/s13287-017-0731-y.	rod electrophysiology trait	not specified	35 days	4	143.41	uV	12.18	24.35	electroretinography	retina	hPDLSC transplant	14	days			109854	3157
RCS-p+/LavRrrc	scotopic B wave amplitude of ERG waveform	gene transfer of the lin-28 homolog B gene using an adenovirus vector (5250000 PFU) then controlled exposure to darkness (for 12 hours)	Tao Z, et al., Oncotarget. 2016 Aug 2;7(31):49368-49383. doi: 10.18632/oncotarget.10343.	rod electrophysiology trait	both	34 days	8	79.0	uV	43.0	121.62	electroretinography	cornea	subretinal injection	14	days	adenovirus	b-wave amplitude ERG	108379	3121
RCS-p+/LavRrrc	scotopic B wave amplitude of ERG waveform	control condition then controlled exposure to darkness (for 12 hours)	Tao Z, et al., Oncotarget. 2016 Aug 2;7(31):49368-49383. doi: 10.18632/oncotarget.10343.	rod electrophysiology trait	both	48 days	5	48.0	uV	26.0	58.14	electroretinography			0		untreated control	b-wave amplitude ERG	108383	3121
RCS-p+/LavRrrc	scotopic B wave amplitude of ERG waveform	2-methyl-6-(phenylethynyl)pyridine (200 umol) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-2.5 log(cd x m/s2))	Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z.	rod electrophysiology trait	both	39 days	7	83.4	uV	14.8	39.16	electroretinography	cornea	subretinal injection	4	days	pbs	a wave amplitude ERG	108543	3123
RCS-p+/LavRrrc	scotopic B wave amplitude of ERG waveform	2-methyl-6-(phenylethynyl)pyridine (200 umol) then controlled exposure to darkness (for 12 hours) then visible light stimulus (0.5 log(cd x m/s2))	Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z.	rod electrophysiology trait	both	39 days	7	233.29	uV	18.61	49.24	electroretinography	cornea	subretinal injection	4	days	pbs	a wave amplitude ERG	108546	3123
RCS-p+/LavRrrc	scotopic B wave amplitude of ERG waveform	phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-4.5 log(cd x m/s2))	Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z.	rod electrophysiology trait	both	39 days	7	10.28	uV	1.69	4.47	electroretinography	cornea	subretinal injection	4	days	pbs	b-wave amplitude ERG	108554	3123

Gene Annotator (Functional Annotation) unavailable	Gene Annotator (Annotation Distribution) unavailable	Variant Visualizer (Genomic Variants) unavailble Variant Visualizer (Genomic Variants) unavailable
Gene Annotator (Functional Annotation)	Gene Annotator (Annotation Distribution)	Variant Visualizer (Genomic Variants)

InterViewer (Protein-Protein Interactions) unavailable	Gviewer (Genome Viewer) unavailable	Variant Visualizer (Damaging Variants) unavailble Variant Visualizer (Damaging Variants) unavailable
InterViewer (Protein-Protein Interactions)	GViewer (Genome Viewer)	Variant Visualizer (Damaging Variants)

Gene Annotator (Annotation Comparison) unavailable	OLGA (Gene List Generator) unavailable
Gene Annotator (Annotation Comparison)	OLGA (Gene List Generator)	Excel (Download)

MOET (Multi-Ontology Enrichement) unavailable	GOLF (Gene-Ortholog Location Finder) unavailable
MOET (Multi-Ontology Enrichement)	GOLF (Gene-Ortholog Location Finder)

Create Name:

Description:

Send us a Message

Phenominer Database Results (125 results)